Co-Founder CSO

Dr. Takahiro Ochiya is an authoritative researcher of EVs and microRNA. He was the first to develop a method for producing liver stem/progenitor cells from mature liver cells. Dr. Ochiya is a professor at Tokyo Medical University and the former Chief of Molecular Cell Research at the Japan National Cancer Center. He received his Ph.D. from Osaka University and conducted post-doctoral studies at the La Jolla Cancer Research Foundation (Sanford Burnham Prebys, San Diego, California).

​

​

CEO

Kosuke has over 15 years of experience in business development across private companies and start-ups. He has led cross-border teams in the UK, Japan, and throughout APAC, driving turnaround projects, M&A activities, and contributing significantly to the growth and value creation of multiple ventures. He holds an MBA from Hult International Business School and a BBA in Hospitality Management from Les Roches.​

​

Advisor

Head of Department

Department of Hepatology,

Tokyo Metropolitan Komagome Hospital

 

Dr. Kimura is an expert in hepatology, with a particular focus on the development of drugs to treat liver cirrhosis. He has conducted multiple investigator-initiated clinical trials for cirrhosis and has contributed to research by the American Association for the Study of Liver Diseases (AASLD). He graduated from Gifu University School of Medicine and completed his doctoral course at Gifu University Graduate School of Medicine. Dr. Kimura was also a postdoctoral researcher at the Scripps Research Institute (Prof. Chisari FV).

Advisor

Professor

Division of Pharmacotherapeutics,

Keio University Faculty of Pharmacy​

 

Dr. Matsuzaki was a Specially Appointed Researcher at the Department of Molecular and Cellular Therapy at the National Cancer Center (Dr. Ochiya’s Group), where he contributed to the identification of serum microRNA biomarkers for early-stage cancer detection. He also served as a postdoctoral researcher at the UCSF Diabetes Center. Dr. Matsuzaki graduated from Keio University School of Medicine, and completed his doctoral course at Keio University Graduate School of Medicine.

Advisor

Assistant Professor

Waseda Institute for Advanced Study, Waseda University

 

Dr. Nishida-Aoki is a cancer biologist who studies tumor microenvironments. She was trained as a Postdoctoral Fellow at the National Cancer Center Research Institute and a JSPS Research Fellow at the Fred Hutchinson Cancer Research Center. During her postdoctoral studies, she proved the therapeutic efficacy of EV-targeting therapy in a preclinical breast cancer model. Dr. Nishida-Aoki graduated from Kyoto University Graduate School of Agriculture.